Cargando…
Factors Related to Major Bleeding After Ticagrelor Therapy: Results from the TICO Trial
BACKGROUND: There is a lack of data on factors that are related to clinically relevant bleeding after ticagrelor treatment. We investigated the clinical and procedural factors related to major bleeding in patients with acute coronary syndrome treated with ticagrelor after coronary stent implantation...
Autores principales: | Cho, Jae Young, Lee, Seung‐Yul, Yun, Kyeong Ho, Kim, Byeong‐Keuk, Hong, Sung‐Jin, Ko, Jum Suk, Rhee, Sang Jae, Oh, Seok Kyu, Shin, Dong‐Ho, Ahn, Chul‐Min, Kim, Jung‐Sun, Ko, Young‐Guk, Choi, Donghoon, Hong, Myeong‐Ki, Jang, Yangsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174385/ https://www.ncbi.nlm.nih.gov/pubmed/33739127 http://dx.doi.org/10.1161/JAHA.120.019630 |
Ejemplares similares
-
Ischemic and Bleeding Events of Ticagrelor Monotherapy in Korean Patients With and Without Diabetes Mellitus: Insights From the TICO Trial
por: Yun, Kyeong Ho, et al.
Publicado: (2021) -
Age‐Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial
por: Kim, Byung Gyu, et al.
Publicado: (2021) -
Clinical implication of ticagrelor monotherapy in patients with small vessel coronary artery disease: results from the TICO randomized trial
por: Cho, Jae Young, et al.
Publicado: (2023) -
Body mass index affecting ticagrelor monotherapy vs. ticagrelor with aspirin in patients with acute coronary syndrome: A pre-specified sub-analysis of the TICO randomized trial
por: Kim, Byung Gyu, et al.
Publicado: (2023) -
Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial
por: Lee, Yong-Joon, et al.
Publicado: (2021)